Coloplast A/S
COM · CUSIP 19624Y101
1
institutional holders
-4 vs Q1 2020
$0reported value*
0 new
0 added
0 reduced
4 sold out
net sold ≈ $315.0k (-22.8k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2020
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 8 |
| Q1 2020 | 5 |
| Q2 2020 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 3 | 4 |
| Q2 2020 | 0 | 4 |
Biggest buyers
| None |
Biggest sellers
| EQUITABLE TRUST CO | Sold out | -11.5k |
| GLENMEDE TRUST CO NA | Sold out | -6.4k |
| Lenox Wealth Management, Inc. | Sold out | -4.1k |
| MAR VISTA INVESTMENT PARTNERS LLC | Sold out | -789 |
Holders, Q2 2020
| Manager | Shares | Change |
|---|---|---|
| IFP Advisors, Inc 0.00% of their portfolio | 0 $0 | Unchanged |